tildrakizumab
Defer initiation and continuation of therapy to outpatient setting. Usually managed as patient own medication/patient specific prescription. Reimbursement and patient assistance program status to be evaluated prior to drug initiation.
Reviewed: October 2020 (Ilumya)
Defer initiation and continuation of therapy to outpatient setting. Usually managed as patient own medication/patient specific prescription. Reimbursement and patient assistance program status to be evaluated prior to drug initiation.
Reviewed: October 2020 (Ilumya)